- Home
- Equities - Stocks - Shares
- Company Press Releases
- Nordhealth AS - Invitation To Q3 2022 Presentation
Nordhealth AS - Invitation to Q3 2022 presentation
21 Nov 2022 08:12 CET
Issuer
Nordhealth AS
Nordhealth will report and present its Q3 2022 results on Friday the 25th of
November 2022.
The results will be presented in a live presentation and subsequent Q&A session
with CEO Charles MacBain and CFO Mari Orttenvuori on the 25th of November at
13:00 CET.
Please use the following link to attend: https://us02web.zoom.us/j/82134750106
The presentation will be recorded and made available on www.nordhealth.com. The
presentation material for Q3 will be available on 25 November 2022 at 07:30 am
CET on www.newsweb.no and on Nordhealth's IR
website https://nordhealth.com/investor/news-and-documents/
For further information, please contact:
Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200
Mari Orttenvuori, CFO mari.orttenvuori@nordhealth.com +358 46 8765 233
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 10,000 clinics and hospitals located in over 30
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 400
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).
More information:
Access the news on Oslo Bors NewsWeb site
Source
Nordhealth AS
Provider
Oslo Børs Newspoint
Company Name
NORDHEALTH AS A-AKSJER
ISIN
NO0011002651
Symbol
NORDH
Market
Euronext Growth